Cancer CD39 Drives Metabolic Adaption and Mal-Differentiation of CD4+ T Cells in Patients with Non-Small-Cell Lung Cancer

Scientists demonstrated that human non-small-cell lung cancer cells, including tumor cell lines and primary tumor cells from clinical patients, efficiently drive the metabolic adaption of human CD4+ T cells, instructing differentiation of regulatory T cells while inhibiting effector T cells.